XSXE:F:F-Xtrackers - Stoxx Europe 600 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 120.36

Change

+1.20 (+1.01)%

Market Cap

USD 8.92M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.07 (+0.25%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.15 (+0.29%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.16 (+0.28%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.07 (+0.43%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.45 (+0.60%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

-0.77 (-0.70%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.23%)

USD 38.52B
0ZC:F Zscaler Inc

+3.40 (+1.90%)

USD 37.92B

ETFs Containing XSXE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.21% 63% D 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.21% 62% D 48% F
Trailing 12 Months  
Capital Gain 9.48% 51% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.48% 47% F 48% F
Trailing 5 Years  
Capital Gain 35.36% 66% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.36% 65% D 48% F
Average Annual (5 Year Horizon)  
Capital Gain 11.15% 72% C 67% D+
Dividend Return 11.15% 70% C- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.54% 54% F 85% B
Risk Adjusted Return 88.92% 87% B+ 91% A-
Market Capitalization 8.92M 3% F 11% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.